NR1H4 and metabolic dysfunction-associated steatotic liver disease: On the other hand, FXR activation may reduce NAFLD inhibiting lipogenesis, hepatic inflammation, and fibrosis in rats, maintaining intestinal barrier integrity and thus protecting the liver from bacteria-derived inflammatory signals [40,107].